Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 52, Issue 3, Pages 1179-1181Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01108-07
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01 RR000052, RR00052] Funding Source: Medline
Ask authors/readers for more resources
Rifaximin is an oral antibiotic indicated for treatment of traveler's diarrhea. Rifaximin pharmacokinetics were evaluated in individuals challenged with Shigella flexneri. Peak plasma rifaximin concentrations were low after nine consecutive doses, and no accumulation was observed. Rifaximin serum levels were minimal and similar to those previously reported in studies of healthy volunteers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available